4.3 Review

Functionally important amino acid residues in the transient receptor potential vanilloid 1 (TRPV1) ion channel - an overview of the current mutational data

期刊

MOLECULAR PAIN
卷 9, 期 -, 页码 -

出版社

SAGE PUBLICATIONS INC
DOI: 10.1186/1744-8069-9-30

关键词

TRPV1; Vanilloid; Amino acid; Mutants; Molecular modelling; Structure

资金

  1. National Office for Research and Technology [OMFB-01630, OMFB-01703, OMFB-01576/2006, BAROSS_DA07-DA_TECH_07-2008-0043, OM-00051/2005, OMFB-01575/2006, ERC_HU_09 3D_TRPV1 OMFB-01813/2009, TAMOP-4.2.1. B-09/1/KONV]
  2. Marie Curie European Re-integration Grant [MCIRG030854-PAINKILLER]
  3. Anyos Jedlik Program [NKFP-1-00019/2005, GVOP-3.3.1-05/1.-2005-05-0057/3.0, BAROSS_DA07-DA_TECH_07-2008-0028]
  4. Hungarian Ministry of Health [552/2006]

向作者/读者索取更多资源

This review aims to create an overview of the currently available results of site-directed mutagenesis studies on transient receptor potential vanilloid type 1 (TRPV1) receptor. Systematization of the vast number of data on the functionally important amino acid mutations of TRPV1 may provide a clearer picture of this field, and may promote a better understanding of the relationship between the structure and function of TRPV1. The review summarizes information on 112 unique mutated sites along the TRPV1, exchanged to multiple different residues in many cases. These mutations influence the effect or binding of different agonists, antagonists, and channel blockers, alter the responsiveness to heat, acid, and voltage dependence, affect the channel pore characteristics, and influence the regulation of the receptor function by phosphorylation, glycosylation, calmodulin, PIP2, ATP, and lipid binding. The main goal of this paper is to publish the above mentioned data in a form that facilitates in silico molecular modelling of the receptor by promoting easier establishment of boundary conditions. The better understanding of the structure-function relationship of TRPV1 may promote discovery of new, promising, more effective and safe drugs for treatment of neurogenic inflammation and pain-related diseases and may offer new opportunities for therapeutic interventions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据